Targeting the METTL14/Wnt9a/β-catenin pathway with pharmacological inhibitors enhances radiotherapy and immunotherapy efficacy in non-small cell lung cancer
{{output}}
Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality, with its molecular heterogeneity posing a therapeutic challenge. This study investigates the pharmacologically targetable METTL14-mediated pathway in modulating cancer stemness and... ...
